Navigation Links
Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
Date:7/10/2008

s relating to cord blood services, and from the sale of sub-license agreements by licensees.

As of May 31, 2008, the Company had approximately $4.2 million in available cash, cash equivalents, marketable securities and other investments. The Company had no long-term debt at the end of the quarter.

"We continue to be encouraged by Cryo-Cell's improved performance in the second quarter of 2008. In accordance with our long-term strategic plan, we believe that the Company is showing significant progress with the launch of our new product, C'elle, combined with the realization of significant operating efficiencies that have resulted in year over year expense reductions of 21% in the first half of fiscal 2008," stated Mercedes Walton, Chairman and Chief Executive Officer. "In 2006, following nine consecutive quarters of profitability spanning the first quarter of 2004 through the second quarter of 2006, Cryo-Cell's Board of Directors made the deliberate decision to forsake continued near-term profitability in order to invest in the long-term growth of our business. During the first half of fiscal 2008, Cryo-Cell has demonstrated continuing progress towards profitability and we anticipate future progress in 2008 and beyond based on our solid platform as an industry leader of innovative stem cell solutions."

"Notwithstanding formidable challenges facing our business associated with the overall impact of the domestic economy on discretionary consumer and family spending, intensified industry competition and the cost of new product development, Cryo-Cell has now introduced a highly differentiated new service in the U.S. and is making significant progress toward introducing the new service in the global market place based on our expansive intellectual property portfolio. In parallel, the Company has also achieved impressive reductions in marketing, general and administrative expenses." Walton continued, "Our recent agreement with LifeCell International Pri
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
2. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
3. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
4. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
5. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
6. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
7. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
9. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
10. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
11. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... CARLOS, Calif., Dec. 2 SleepQuest...lued accreditation from the Joint Commission on th...HO) by demonstrating compliance,with national sta... "In becoming accredited, SleepQuest was evaluate...t Commission,s home care service survey team,",sa...
(Date:12/2/2008)...UMBIA, Md., Dec. 2 Marte...ced that it intends to release the results of its ..., 2008, at approximately 4:00 p.m. Eastern Time (E... will conduct a conference call to discuss these r... listen to the call live via webcast by visiting M...
(Date:12/2/2008)...Track to File NDA with FDA in Early to Mid-2009 ,...FirstCall/ -- Strativa Pharmaceuticals, the propri...anies, Inc. (NYSE: PRX ) today announced that it...ccessful completion of all pivotal bioequivalence .... The ondansetron thin film product is being devel...
(Date:12/2/2008)... DIEGO, Dec. 2 BrainCells Inc. (BC...tform technology to identify and,develop compound...reatment of,central nervous system (CNS) diseases...mpson to its board of directors. Thompson is a vet...ar tenure at Eli Lilly and Co. where he,focused o...
Breaking Biology Technology:SleepQuest Achieves Coveted Accreditation 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 2BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 3
...W. Turek and Guy C. Le Breton, Department of Pharm...ege of Medicine, Chicago, IL 60612.,Address corr... Department,of Pharmacology M/C 868, University ...l: jturek1@icarus.uic.edu , , ...mboxane A 2 (TXA 2 ) receptor, in addition to its...
.... Crispin,* Ru Chen,* Michael B. Kimmey,** Teresa ...s of Pathology and , **Medicine, Divisio...eattle, , Washington. , , ...is the fourth leading cause of cancer death in the...he time of diagnosis, 9699% of , patients...
...ller and Theresa Redila-Flores , Bio-Rad... , Introduction , Denat...f several methods , that can be used to s..., point mutations. In DGGE, the denaturin... of uniform temperature and a linear denaturant ...
... Introduction , The macular region of t...r , vision and most of the high, ..., known as the macula , lutea, or yellow ...f two closely-related compounds, lutein and zeaxan... dihydroxy-a-carotenes which differ in the positi...
Other Biology Technology:Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 2Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 3Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 4Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 5Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 2Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 3DGGE Analysis Using the DCode System, Rev B 2DGGE Analysis Using the DCode System, Rev B 3Purification of the Components of Human Macular Carotenoid-Binding Complex, , Rev A 2Purification of the Components of Human Macular Carotenoid-Binding Complex, , Rev A 3
(Date:12/1/2008)...mber 2008 - The International Atomic Energy Agency... plant breeding technique that could bolster effor...hunger trap. , IAEA scientists use radiation to ...o harsh climate conditions such as drought or floo...nsect pests. Called mutation induction, the techni...
(Date:12/1/2008).... Scientists around the world may benefit from a ...that will help them to home in on the parts of pro... Sidow, PhD, associate professor of pathology and ...edicine, recently launched the novel bioinformatic...termining the role different proteins play in a wi...
(Date:12/1/2008)...la. The University of Florida, keeper of the worl... national records collection for another toothy ma... long rostrum or "saw" that makes it a popular cur...ome a historical and cultural icon that is rapidly...gist and curator of both the International Shark A...
(Date:12/1/2008)...if. For their landmark research leading to the de...farmers in flood-prone areas worldwide, Julia Bai... Davis and David Mackill of the International Ri...onored by the U.S. Department of Agriculture (USDA...Discovery Award. , The three scientists are, or ...
Breaking Biology News(10 mins):Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2UC Riverside rice geneticist receives high honor from US Department of Agriculture 2UC Riverside rice geneticist receives high honor from US Department of Agriculture 3Lifespring Health Sponsors the 30th Annual Napa Valley Marathon in an Effort to Promote Health and Fitness in the Northern California Community 12776 1AUDIO from Medialink and Transitions 3A Understanding the Dangers of UV Rays 12772 1HIV Drug in Microbicide Gel Safe for Daily Use 12771 1HIV Drug in Microbicide Gel Safe for Daily Use 12771 2Health Groups Launch Ad Campaign Supporting 70 Cent Increase in Kentucky Cigarette Tax 12768 1Health Groups Launch Ad Campaign Supporting 70 Cent Increase in Kentucky Cigarette Tax 12768 2
...archers have developed a "biobullet" that could he...S. waterways for nearly two decades clogging water...pecies and causing billions of dollars in industri...xins that dissolve within a zebra mussel,s digesti...liminating one of the world,s "most important econ...
...vings from sawmills can be used to produce an orga...containers. Moreover, this substrate has the advan...than other, imported ones such as peat or coconut ... the Public University of Navarre who, jointly wit...veloped this substrate material. The product has a...
...t The University of Manchester have created a new ...ronment for culturing cells in 3D, as published in...e gel is the first pH neutral material made from c...o provide an environment in which cells can be cul... the gel mimics the properties of cell scaffolds w...
... of human DNA have different structures that are t...ern Medical Center researchers have found in a stu...e study ?published in the Feb. 3 issue of the jour...ich are capped by segments called telomeres. Each ... they become too short, the aging cell can no long...
Other Biology News:'Biobullets' fight harmful mussels 2New organic substrate 2Manchester scientists create new bio-gel for 3D cell culture 2DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2
...re easily imported for data analysis , A...edious spot, template a... Extensive background and signal options to op... Characterize more precisely through group...
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm.
...tains 400 unique human proteins on a 1x3 inch nitr...ss section of all cellular proteins, are arrayed i...al control proteins and a specific chip layout gua...p protein microarrays are high-density protein bio...
...tains 400 unique human proteins on a 1x3 inch nitr...ntracellular proteins (IP) according to Gene Ontol...or high-quality results. Additional control protei...ity and reproducibility., UNIchip protein microarr...
Biology Products: